RedCarpetLife
1233
In the world today
Wang Junmin

Wang Junmin

W. Junmin
-0.14% | - $-4.70M
$3.41 B ₹ 31,050 Cr
Real Time Net Worth #1233 Ranking as of 21 Feb 2026 By Forbes

More on Wang Junmin

Gender

Male

Age

58Y

Country

China

Born On

January, 1968

Deceased

No

Relationship Status

Married

Children

Unknown

Education

Shenyang Pharmaceutical University - Bachelor'S

Designation Info :

Self-Made

Yes

Entrepreneur Type

Self-Made (Pharmaceuticals)

Primary Organization

Haisco Pharmaceutical Group

Titles

Chairman

Sources of Wealth

Pharmaceuticals

Industry

Healthcare, Pharmaceuticals

About Wang Junmin


W ang Junmin is the chairman of Haisco Pharmaceutical Group, a Chinese pharmaceutical company specializing in enteral nutrition and parenteral nutrition products. He founded the company in 2000, initially focusing on the development and marketing of specialized drugs. A graduate of Shenyang Pharmaceutical University, Wang utilized his academic background to steer Haisco toward becoming a research-driven enterprise.

Based in Tibet (with operational headquarters in Chengdu), Haisco has grown into a major supplier of active pharmaceutical ingredients (APIs) and finished formulations. Wang led the company to a public listing on the Shenzhen Stock Exchange in 2012. He continues to drive the company's R&D strategy, focusing on innovative treatments for anesthesia, diabetes, and other therapeutic areas.

Advertisement

Quick Reads


Early Life and Background


Wang Junmin is a Chinese businessman, the Chairman of Haisco Pharmaceutical Group (SZSE: 002653), a Tibet-based maker of active pharmaceutical ingredients (APIs).

Haisco was founded in 2000 and currently has more than 4,000 employees. Wang holds a bachelor's degree from Shenyang Pharmaceutical University, providing the technical foundation for his leadership in the complex pharmaceutical manufacturing sector.

  • Core Company: Haisco Pharmaceutical Group (Active pharmaceutical ingredients).
  • Founding: Founded in 2000.
  • Education: Holds a bachelor's degree from Shenyang Pharmaceutical University.

Career Journey of Wang Junmin


Wang Junmin's career is defined by his successful move into pharmaceutical manufacturing. His structural achievement is tied to founding and scaling Haisco Pharmaceutical Group into a major supplier of Active Pharmaceutical Ingredients (APIs), essential components for drug production.

The company's scale, employing more than 4,000 people, and its focus on APIs underscore its importance in the healthcare supply chain.

  • Scale: Haisco currently has more than 4,000 employees.

Advertisement

Wang Junmin's Timeline


2000:

Founded Haisco Pharmaceutical Group.

Ongoing:

Continues as Chairman.

Major Business Ventures and Investments


Wang Junmin's wealth is concentrated in his founding equity and continued leadership of the publicly traded pharmaceutical giant, Haisco Pharmaceutical Group.

  • Haisco Pharmaceutical Group (Chairman): Tibet-based maker of active pharmaceutical ingredients.
  • Sector Focus: Pharmaceutical manufacturing, APIs, and biotechnology.
  • Founding: Founded in 2000.

Advertisement

Philanthropy and Social Impact


Fashion, Style, and Lifestyle


Advertisement

Quotes and Philosophy


No publicly available quotes.

Fun Facts & Trivia


  • He chairs Haisco Pharmaceutical Group, a Tibet-based maker of active pharmaceutical ingredients.
  • He holds a bachelor's degree from Shenyang Pharmaceutical University.
  • Founded in 2000, Haisco currently has more than 4,000 employees.

Advertisement

More Profiles


Leopoldo Espinosa Abdalá

0% | $0.00M

Matthew Pritzker

+34.3% | +$582.45M

You May Like


Sources & References


This profile is compiled from verified biographical and financial records:

  • Wealth Data: Real-time tracking and historical data from Forbes Billionaires and the Bloomberg Billionaires Index.
  • Biographical Records: Educational and career history sourced from Reuters, The Wall Street Journal, and official university alumni directories.
  • Regulatory Filings: Shareholder and executive disclosures from stock exchange databases, including HKEX, SSE, SZSE, and SEC EDGAR.
  • Corporate History: Primary data from annual company reports, founding charters, and verified press announcements.

All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.

If you find any inaccuracies, please report them to admin@redcarpetlife.in

Sponsored Content